
IXICO PLC — Investor Relations & Filings
IXICO PLC is a clinical research and data analytics company specializing in neuroscience. It provides neuroimaging and digital biomarker analytics to biopharmaceutical firms conducting clinical trials for neurological disorders. The company utilizes its proprietary, AI-driven technology platform to manage and analyze complex imaging and digital health data. This platform deploys disease-specific algorithms to generate reliable clinical data and precision insights, aiming to accelerate research and development decision-making, de-risk clinical studies, and support the advancement of new therapies for conditions such as Alzheimer's and Huntington's disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Validation of Neuroimaging Technology Platform | 2026-02-26 | English | |
| Correction: c.£1.5 million Contract Extension | 2026-02-12 | English | |
| c.£1.5 million Contract Extension | 2026-02-12 | English | |
| Appointment of Chief Commercial Officer | 2026-02-05 | English | |
| Results of AGM | 2026-01-23 | English | |
| Share option award | 2025-12-09 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
5 filings
| |||||
| 34565951 | Validation of Neuroimaging Technology Platform | 2026-02-26 | English | ||
| 34559240 | Correction: c.£1.5 million Contract Extension | 2026-02-12 | English | ||
| 34559189 | c.£1.5 million Contract Extension | 2026-02-12 | English | ||
| 14490658 | Appointment of Chief Commercial Officer | 2026-02-05 | English | ||
| 13284002 | Results of AGM | 2026-01-23 | English | ||
|
2025
10 filings
| |||||
| 9685042 | Share option award | 2025-12-09 | English | ||
| 9684961 | Financial Results for year ended 30 September 2025 | 2025-12-09 | English | ||
| 8952390 | Operational Update | 2025-12-01 | English | ||
| 8718259 | Notice of 2025 Full Year Results and IMC | 2025-11-27 | English | ||
| 8443496 | Clinical Trial Contract Win | 2025-11-17 | English | ||
| 8068069 | Capital Markets Day Presentation and Video | 2025-11-03 | English | ||
| 8026474 | Trading Update | 2025-10-16 | English | ||
| 8024595 | New contract win and contract extension | 2025-10-15 | English | ||
| 11391959 | Notice of Capital Markets Day | 2025-09-30 | English | ||
| 7739446 | Contract Win | 2025-08-12 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for IXICO PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
IXICO PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7723/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7723 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7723 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7723 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7723}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IXICO PLC (id: 7723)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.